- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED Apr 22, 2024
Companys with strong funding and high growth potential
89 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BOVN.F | kr4.70 | 0% | n/a | kr2.7b | kr12.58 | PS9.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.55 | -11.9% | -38.2% | US$220.6m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.10 | 0.5% | 66.7% | US$214.0m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | Pharmaceuticals & Biotech | ||
IPHY.F | €2.65 | 0% | n/a | €170.6m | €7.87 | PS2.8x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
AVHH.L | US$2.10 | 0% | -22.2% | US$222.9m | US$6.33 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
0ABW | kr6.37 | 8.5% | -17.7% | kr1.9b | kr13.13 | PS32.4x | E85.4% | n/a | Pharmaceuticals & Biotech | ||
0H22 | kr23.20 | 22.0% | -16.5% | kr1.5b | kr82.64 | PS21.5x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
AVH | US$2.80 | -6.0% | -35.3% | US$220.6m | US$8.54 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
AVH | US$2.69 | -9.7% | -37.7% | US$220.6m | US$8.20 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
0EVI | €2.16 | -7.5% | -20.7% | €175.0m | €6.27 | PS2.8x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
ARDX | US$6.51 | -3.0% | 41.2% | US$1.5b | US$13.50 | PS12.2x | E59.6% | n/a | Pharmaceuticals & Biotech | ||
IPHA | €2.43 | -6.4% | -15.5% | €175.0m | €7.02 | PS2.8x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
0L35 | US$114.94 | -5.1% | -9.6% | US$10.9b | US$161.70 | PS8.8x | E42.7% | n/a | Pharmaceuticals & Biotech | ||
0JDK | US$11.37 | -5.6% | 108.4% | US$3.2b | US$26.11 | PS2659.2x | E61.7% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$116.96 | -0.3% | -5.1% | US$11.0b | US$164.54 | PS8.8x | E42.7% | n/a | Pharmaceuticals & Biotech | ||
MGTX | US$5.02 | -7.2% | -5.1% | US$322.4m | US$21.60 | PS23x | E52.8% | n/a | Pharmaceuticals & Biotech | ||
ACAD | US$16.99 | -0.5% | -15.5% | US$2.8b | US$29.06 | PS3.9x | E40.8% | n/a | Pharmaceuticals & Biotech | ||
CAPR | US$4.94 | -16.7% | 25.7% | US$155.6m | US$21.00 | PS6.2x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$213.49 | -8.4% | -27.8% | US$4.5b | US$377.07 | PB11.1x | E61.4% | n/a | Pharmaceuticals & Biotech |